Newcastle, Australia

Connor O'Meara


 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Connor O'Meara

Introduction

Connor O'Meara is an accomplished inventor based in Newcastle, Australia. He has made significant contributions to the field of medical research, particularly in the development of compounds aimed at treating and preventing various pathologies. With a total of three patents to his name, O'Meara's work focuses on addressing critical health issues through innovative solutions.

Latest Patents

O'Meara's latest patents include groundbreaking inventions related to compounds for treating and preventing extracellular histone mediated pathologies. These compounds exhibit high chemical stability and are designed to inhibit the pathological activity of extracellular histones in subjects. His work specifically addresses ailments such as sepsis, systemic immune response syndrome (SIRS), and ischemia reperfusion injury (IRI). One notable compound is β-O-methyl cellobioside sulfate (mCBS), which has shown promise in the therapy of these conditions.

Another significant patent involves compounds for treating and preventing NET (neutrophil extracellular traps) associated complications. Similar to his previous work, these compounds are characterized by high chemical stability and aim to ameliorate NET mediated ailments. The methods and uses of β-O-methyl cellobioside sulfate (mCBS) or its pharmaceutically acceptable salts are central to this invention, providing potential therapeutic benefits for a range of NET mediated ailments.

Career Highlights

Throughout his career, Connor O'Meara has worked with prestigious institutions such as The Australian National University and Griffith University. His research has been instrumental in advancing the understanding of extracellular histones and NETs, leading to innovative therapeutic approaches.

Collaborations

O'Meara has collaborated with notable colleagues, including Christopher Richard Parish and Lucy Coupland. These partnerships have fostered a collaborative environment that enhances the research and development of his innovative compounds.

Conclusion

Connor O'Meara's contributions to medical research through his patents demonstrate his commitment to addressing significant health challenges. His innovative compounds hold promise for improving patient outcomes in various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…